« Back
Home /
Delanzomib

Delanzomib

Item no.	CAPS-C07567-50mg
Manufacturer	Capsid Biotechnology
CASRN	847499-27-8
Amount	50 mg
Quantity options	10 mM/1 ml 50 mg 5 mg
Category	Reagents & Chemicals Material Science Metal Compounds
Type	Chemicals
Specific against	other
Smiles	B(C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	CEP-18770
Available
Storage Conditions	2 years -80 in solvent
Small Target	Proteasome
Big Target	Proteases
Information	Delanzomib is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question